Please login to the form below

Not currently logged in
Email:
Password:

granulomatosis

This page shows the latest granulomatosis news and features for those working in and with pharma, biotech and healthcare.

CHMP backs Sanofi’s all-oral sleeping sickness drug

CHMP backs Sanofi’s all-oral sleeping sickness drug

remission with minimal residual disease greater than or equal to 0.1%, and also backed Roche’s MabThera (rituximab) for adults with severe, active granulomatosis with polyangiitis and microscopic polyangiitis in

Latest news

  • Roche’s MabThera ends drug drought for serious skin disease Roche’s MabThera ends drug drought for serious skin disease

    Rituximab already has a long list of approved indications – including autoimmune disease rheumatoid arthritis, granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA) – and despite being on the market for more than

  • GSK gets another approval for Nucala in US GSK gets another approval for Nucala in US

    The US regulator gave the go-ahead yesterday to use Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that causes vasculitis, inflammation in

  • GSK preps COPD filing for asthma pioneer Nucala GSK preps COPD filing for asthma pioneer Nucala

    with eosinophilic granulomatosis with polyangiitis (EGPA), a rare disorder characterised by widespread inflammation in the walls of small blood vessels.  It has also started trials of the drug in severe nasal

  • GSK starts trial of Nucala to seek alternate indications GSK starts trial of Nucala to seek alternate indications

    levels of eosinophil white cells - including chronic obstructive pulmonary disease (COPD), severe atopic dermatitis, hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis.

  • Mundipharma to launch first MabThera biosimilar in EU Mundipharma to launch first MabThera biosimilar in EU

    The biosimilar has also been approved for use in adults with severe rheumatoid arthritis and in combination with glucocorticoids for the treatment of granulomatosis with poylangiitis and micropscopic polyangiitis.

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics